The histone deacetylase inhibitor SAHA induces HSP60 nitration and its extracellular release by exosomal vesicles in human lung-derived carcinoma cells

Claudia Campanella, Antonella D'Anneo, Antonella Marino Gammazza, Celeste Caruso Bavisotto, Rosario Barone, Sonia Emanuele, Filippa Lo Cascio, Emanuele Mocciaro, Stefano Fais, Everly Conway De Macario, Alberto J.L. Macario, Francesco Cappello, Marianna Lauricella

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

HSP60 undergoes changes in quantity and distribution in some types of tumors suggesting a participation of the chaperonin in the mechanism of transformation and cancer progression. Suberoylanilide hydroxamic acid (SAHA), a member of a family of histone deacetylase inhibitors (HDACi), has anti-cancer potential but its interaction, if any, with HSP60 has not been elucidated. We investigated the effects of SAHA in a human lung-derived carcinoma cell line (H292). We analysed cell viability and cycle; oxidative stress markers; mitochondrial integrity; HSP60 protein and mRNA levels; and HSP60 post-translational modifications, and its secretion. We found that SAHA is cytotoxic for H292 cells, interrupting the cycle at the G2/M phase, which is followed by death; cytotoxicity is associated with oxidative stress, mitochondrial damage, and diminution of intracellular levels of HSP60; HSP60 undergoes a post-translational modification and becomes nitrated; and nitrated HSP60 is exported via exosomes. We propose that SAHA causes ROS overproduction and mitochondrial dysfunction, which leads to HSP60 nitration and release into the intercellular space and circulation to interact with the immune system. These successive steps might constitute the mechanism of the anti-tumor action of SAHA and provide a basis to design supplementary therapeutic strategies targeting HSP60, which would be more efficacious than the compound alone.

Original languageEnglish (US)
Pages (from-to)28849-28867
Number of pages19
JournalOncotarget
Volume7
Issue number20
DOIs
StatePublished - May 17 2016
Externally publishedYes

Fingerprint

Histone Deacetylase Inhibitors
Carcinoma
Lung
Post Translational Protein Processing
Neoplasms
Cell Cycle
Oxidative Stress
Chaperonins
Exosomes
G2 Phase
Extracellular Space
Cell Division
Immune System
Cell Survival
vorinostat
Cell Line
Messenger RNA
Proteins

Keywords

  • Exosomes
  • Histone deacetylase inhibitor
  • HSP60
  • Oxidative stress
  • SAHA

ASJC Scopus subject areas

  • Oncology

Cite this

Campanella, C., D'Anneo, A., Gammazza, A. M., Bavisotto, C. C., Barone, R., Emanuele, S., ... Lauricella, M. (2016). The histone deacetylase inhibitor SAHA induces HSP60 nitration and its extracellular release by exosomal vesicles in human lung-derived carcinoma cells. Oncotarget, 7(20), 28849-28867. https://doi.org/10.18632/oncotarget.6680

The histone deacetylase inhibitor SAHA induces HSP60 nitration and its extracellular release by exosomal vesicles in human lung-derived carcinoma cells. / Campanella, Claudia; D'Anneo, Antonella; Gammazza, Antonella Marino; Bavisotto, Celeste Caruso; Barone, Rosario; Emanuele, Sonia; Lo Cascio, Filippa; Mocciaro, Emanuele; Fais, Stefano; De Macario, Everly Conway; Macario, Alberto J.L.; Cappello, Francesco; Lauricella, Marianna.

In: Oncotarget, Vol. 7, No. 20, 17.05.2016, p. 28849-28867.

Research output: Contribution to journalArticle

Campanella, C, D'Anneo, A, Gammazza, AM, Bavisotto, CC, Barone, R, Emanuele, S, Lo Cascio, F, Mocciaro, E, Fais, S, De Macario, EC, Macario, AJL, Cappello, F & Lauricella, M 2016, 'The histone deacetylase inhibitor SAHA induces HSP60 nitration and its extracellular release by exosomal vesicles in human lung-derived carcinoma cells', Oncotarget, vol. 7, no. 20, pp. 28849-28867. https://doi.org/10.18632/oncotarget.6680
Campanella, Claudia ; D'Anneo, Antonella ; Gammazza, Antonella Marino ; Bavisotto, Celeste Caruso ; Barone, Rosario ; Emanuele, Sonia ; Lo Cascio, Filippa ; Mocciaro, Emanuele ; Fais, Stefano ; De Macario, Everly Conway ; Macario, Alberto J.L. ; Cappello, Francesco ; Lauricella, Marianna. / The histone deacetylase inhibitor SAHA induces HSP60 nitration and its extracellular release by exosomal vesicles in human lung-derived carcinoma cells. In: Oncotarget. 2016 ; Vol. 7, No. 20. pp. 28849-28867.
@article{622e2ef87dff431f99ed5832e34c38bd,
title = "The histone deacetylase inhibitor SAHA induces HSP60 nitration and its extracellular release by exosomal vesicles in human lung-derived carcinoma cells",
abstract = "HSP60 undergoes changes in quantity and distribution in some types of tumors suggesting a participation of the chaperonin in the mechanism of transformation and cancer progression. Suberoylanilide hydroxamic acid (SAHA), a member of a family of histone deacetylase inhibitors (HDACi), has anti-cancer potential but its interaction, if any, with HSP60 has not been elucidated. We investigated the effects of SAHA in a human lung-derived carcinoma cell line (H292). We analysed cell viability and cycle; oxidative stress markers; mitochondrial integrity; HSP60 protein and mRNA levels; and HSP60 post-translational modifications, and its secretion. We found that SAHA is cytotoxic for H292 cells, interrupting the cycle at the G2/M phase, which is followed by death; cytotoxicity is associated with oxidative stress, mitochondrial damage, and diminution of intracellular levels of HSP60; HSP60 undergoes a post-translational modification and becomes nitrated; and nitrated HSP60 is exported via exosomes. We propose that SAHA causes ROS overproduction and mitochondrial dysfunction, which leads to HSP60 nitration and release into the intercellular space and circulation to interact with the immune system. These successive steps might constitute the mechanism of the anti-tumor action of SAHA and provide a basis to design supplementary therapeutic strategies targeting HSP60, which would be more efficacious than the compound alone.",
keywords = "Exosomes, Histone deacetylase inhibitor, HSP60, Oxidative stress, SAHA",
author = "Claudia Campanella and Antonella D'Anneo and Gammazza, {Antonella Marino} and Bavisotto, {Celeste Caruso} and Rosario Barone and Sonia Emanuele and {Lo Cascio}, Filippa and Emanuele Mocciaro and Stefano Fais and {De Macario}, {Everly Conway} and Macario, {Alberto J.L.} and Francesco Cappello and Marianna Lauricella",
year = "2016",
month = "5",
day = "17",
doi = "10.18632/oncotarget.6680",
language = "English (US)",
volume = "7",
pages = "28849--28867",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "20",

}

TY - JOUR

T1 - The histone deacetylase inhibitor SAHA induces HSP60 nitration and its extracellular release by exosomal vesicles in human lung-derived carcinoma cells

AU - Campanella, Claudia

AU - D'Anneo, Antonella

AU - Gammazza, Antonella Marino

AU - Bavisotto, Celeste Caruso

AU - Barone, Rosario

AU - Emanuele, Sonia

AU - Lo Cascio, Filippa

AU - Mocciaro, Emanuele

AU - Fais, Stefano

AU - De Macario, Everly Conway

AU - Macario, Alberto J.L.

AU - Cappello, Francesco

AU - Lauricella, Marianna

PY - 2016/5/17

Y1 - 2016/5/17

N2 - HSP60 undergoes changes in quantity and distribution in some types of tumors suggesting a participation of the chaperonin in the mechanism of transformation and cancer progression. Suberoylanilide hydroxamic acid (SAHA), a member of a family of histone deacetylase inhibitors (HDACi), has anti-cancer potential but its interaction, if any, with HSP60 has not been elucidated. We investigated the effects of SAHA in a human lung-derived carcinoma cell line (H292). We analysed cell viability and cycle; oxidative stress markers; mitochondrial integrity; HSP60 protein and mRNA levels; and HSP60 post-translational modifications, and its secretion. We found that SAHA is cytotoxic for H292 cells, interrupting the cycle at the G2/M phase, which is followed by death; cytotoxicity is associated with oxidative stress, mitochondrial damage, and diminution of intracellular levels of HSP60; HSP60 undergoes a post-translational modification and becomes nitrated; and nitrated HSP60 is exported via exosomes. We propose that SAHA causes ROS overproduction and mitochondrial dysfunction, which leads to HSP60 nitration and release into the intercellular space and circulation to interact with the immune system. These successive steps might constitute the mechanism of the anti-tumor action of SAHA and provide a basis to design supplementary therapeutic strategies targeting HSP60, which would be more efficacious than the compound alone.

AB - HSP60 undergoes changes in quantity and distribution in some types of tumors suggesting a participation of the chaperonin in the mechanism of transformation and cancer progression. Suberoylanilide hydroxamic acid (SAHA), a member of a family of histone deacetylase inhibitors (HDACi), has anti-cancer potential but its interaction, if any, with HSP60 has not been elucidated. We investigated the effects of SAHA in a human lung-derived carcinoma cell line (H292). We analysed cell viability and cycle; oxidative stress markers; mitochondrial integrity; HSP60 protein and mRNA levels; and HSP60 post-translational modifications, and its secretion. We found that SAHA is cytotoxic for H292 cells, interrupting the cycle at the G2/M phase, which is followed by death; cytotoxicity is associated with oxidative stress, mitochondrial damage, and diminution of intracellular levels of HSP60; HSP60 undergoes a post-translational modification and becomes nitrated; and nitrated HSP60 is exported via exosomes. We propose that SAHA causes ROS overproduction and mitochondrial dysfunction, which leads to HSP60 nitration and release into the intercellular space and circulation to interact with the immune system. These successive steps might constitute the mechanism of the anti-tumor action of SAHA and provide a basis to design supplementary therapeutic strategies targeting HSP60, which would be more efficacious than the compound alone.

KW - Exosomes

KW - Histone deacetylase inhibitor

KW - HSP60

KW - Oxidative stress

KW - SAHA

UR - http://www.scopus.com/inward/record.url?scp=84969895342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969895342&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.6680

DO - 10.18632/oncotarget.6680

M3 - Article

VL - 7

SP - 28849

EP - 28867

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 20

ER -